International Stem Cell Co. (OTCMKTS:ISCO) Short Interest Update

International Stem Cell Co. (OTCMKTS:ISCO) was the recipient of a significant increase in short interest during the month of December. As of December 31st, there was short interest totalling 1,500 shares, an increase of 400.0% from the December 15th total of 300 shares. Based on an average trading volume of 22,400 shares, the short-interest ratio is currently 0.1 days.

International Stem Cell Trading Down 16.7 %

OTCMKTS ISCO traded down $0.02 during trading on Tuesday, hitting $0.10. 10,055 shares of the company’s stock were exchanged, compared to its average volume of 4,939. The stock’s 50 day moving average price is $0.09 and its two-hundred day moving average price is $0.08. International Stem Cell has a fifty-two week low of $0.05 and a fifty-two week high of $0.20. The company has a market cap of $800,000.00, a PE ratio of -1.25 and a beta of 0.21.

About International Stem Cell

International Stem Cell Corporation, a clinical stage biotechnology company, focuses on the development of therapeutic and biomedical products in the United States, Asia, Europe, and internationally. It develops ISC- hpNSC, a neural stem cell program that has completed the Phase I clinical trial for the treatment of Parkinson's disease, as well as for treating stroke and traumatic brain injury.